Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382769 · ClinicalTrials.gov registry record · NA
Hearing Loss in Older Adults Study
A NA study, sponsored by Cochlear.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03382769: Clinical Trial NA study, sponsored by Cochlear.
NCT03382769 is a NA study that was terminated before completion, run by Cochlear. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03382769, a NA study, was terminated before completion, sponsored by Cochlear.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a prospective, 1:1 randomized controlled trial of immediate versus delayed cochlear implantation (CI) on hearing handicap, communicative function, loneliness, mental wellbeing, and cognitive functioning. Participants are randomized 1:1 to an immediate cochlear implant intervention group versus a hearing aid control intervention.
Primary Outcome
The SSQ-12 is comprised of 12 items using the response format on a scale from 0 to 10, were 0 equals no ability and 10 equals perfect ability. These are divided into three sub-scales and the questions 1-5 are from the speech sub-scale, 6-8 from the spatial, and 9-12 from the qualities sub-scale. The three sub-scales are the average of the questions within. A 'not applicable' option is given for each item. Assessment of the impact of cochlear implantation versus continued hearing aid is then cal
Interventions
- DEVICE Cochlear implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-27 |
| Est. Completion | 2020-01-04 |
| Phase | NA |
Why NCT03382769 stopped before completion
NCT03382769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Cochlear implantation is the first listed.
NCT03382769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03382769 about?
NCT03382769 is a clinical study titled "Hearing Loss in Older Adults Study". This is a prospective, 1:1 randomized controlled trial of immediate versus delayed cochlear implantation (CI) on hearing handicap, communicative function, loneliness, mental wellbeing, and cognitive functioning. Participants are randomized 1:1 to an immediate cochlear implant intervention group vers...
What is the current status of trial NCT03382769?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-03-27. Estimated completion is 2020-01-04.
What interventions are being tested in trial NCT03382769?
The interventions under investigation include: Cochlear implantation (DEVICE).
Who is sponsoring clinical trial NCT03382769?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03382769's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI